<IPO>Vaccine Firm Ab&B Bio-Tech Passes HK Listing Hearing
Ab&amp;B Bio-Tech has recently passed the listing hearing on the Hong Kong Stock Exchange, with C...
Ab&B Bio-Tech has recently passed the listing hearing on the Hong Kong Stock Exchange, with CITIC Securities and CMBI acting as its joint sponsors.
According to preliminary information after the hearing, Ab&B Bio-Tech was founded in 2015. It is a China-based vaccine manufacturer. For 1Q ended March 2025, it recorded a revenue of RMB413,000, up nearly 35% YoY, but its loss reached RMB87.317 million during the period, expanding from a loss of RMB63.331 million in the same period of 2024.
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
